Researchers centered at Nagoya University develop a nanowire device able to detect microscopic levels of urinary markers potentially implicated in cancer
Cells communicate with each other through a number of different mechanisms. Some of these mechanisms are well-known: in animals, for example, predatory threats can drive the release of norepinephrine, a hormone that travels through the bloodstream and triggers heart and muscle cells to initiate a “fight-or-flight” response.
A far less familiar mode of cellular transport is the extracellular vesicle (EV). EVs can be thought of as small “chunks” of a cell that are able to pinch off and circulate throughout the body to deliver messenger cargo to other cells. These messengers have become increasingly recognized as crucial mediators of cell-to-cell communication.
In a new study reported in Science Advances, researchers centered at Nagoya University have developed a novel medical device that can efficiently capture these EVs, and potentially use them to screen for cancer.
Video 1: MicroRNA extraction using nanowires
After introducing a urine sample onto the device, extracellular vesicles are captured by a nanowire substrate via electrostatic forces. MicroRNAs can then be directly extracted from the substrate. Takao Yasui
“EVs are potentially useful as clinical markers. The composition of the molecules contained in an EV may provide a diagnostic signature for certain diseases,” lead author Takao Yasui explains. “The ongoing challenge for physicians in any field is to find a non-invasive diagnostic tool that allows them to monitor their patients on a regular basis–for example, a simple urine test.”
Among the many molecules EVs have been found to harbor are microRNAs, which are short pieces of ribonucleic acid that play diverse roles in normal cellular biology. Critically, the presence of certain microRNAs in urine might serve as a red flag for serious conditions such as bladder and prostate cancer. While this important cargo could therefore theoretically aid physicians in cancer diagnoses, there are still many technological hurdles that need to be overcome. One such hurdle: finding a feasible method to capture EVs in sufficient quantities to analyze them in a routine clinical setting.
“The content of EVs in urine is extremely low, at less than 0.01% of the total fluid volume. This is a major barrier to their diagnostic utility,” Yasui notes. Our solution was to embed zinc oxide nanowires into a specialized polymer to create a material that we believed would be highly efficient at capturing these vesicles. Our findings suggest that the device is indeed quite efficient. We obtained a collection rate of over 99%, surpassing ultracentrifugation as well as other methods that are currently being used in the field.”
To test the practicality of their device, the research team compared the microRNAs of EVs isolated from healthy patients with those isolated from patients who were already diagnosed with bladder, prostate, and other forms of cancer. Notably, their technique required only 1 milliliter of urine–far more than the typical “deposit” provided during a routine checkup–and found a substantially greater number and different types of microRNAs compared with the standard ultracentrifugation approach.
Figure 2: Identification of distinct microRNA patterns in healthy donors and cancer patients
Nanowire extraction allowed many microRNAs to be compared at once using urine samples collected from patients. Expression of each microRNA is shown as low/downregulated (blue), intermediate (black), or high/upregulated (yellow). The analysis reveals unique patterns of expression for groups of microRNAs when comparing healthy donors (?) with cancer patients (+). via Takao Yasui
“Finding a specific, reproducible marker to help confirm a cancer diagnosis is difficult. This is especially true for microRNAs, which are a relatively new class of markers in the field,” co-author Yoshinobu Baba explains. “Sometimes finding just one reliable microRNA is considered a success. Using this approach, we were surprised to find that not just one, but whole combinations of microRNAs might be associated with different types of cancers. The findings are preliminary, of course, but we hope our device can help to lay the groundwork for easier ways to diagnose life-threatening diseases as early as possible.”
Learn more: Development of a Nanowire Device to Detect Cancer with a Urine Test
The Latest on: Detecting cancer
[google_news title=”” keyword=”detecting cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Cuttack hospital bid to detect cancer earlyon March 30, 2023 at 10:43 pm
Orissa HC nod to lawyer's hiring as asst public prosecutor 2 patients get kidneys from brain-dead donor at Cuttack hospital Acharya Harihar Post Graduate Institute of Cancer "All the institutes have ...
- Potential to improve early cancer detection lands Elypta prize inspired by Star Trek creatoron March 30, 2023 at 8:42 am
The metabolism-based liquid biopsy improved on the ability of genomic tests to detect stage I cancers in a recent study.
- Chesapeake Fire Dept. offers multi-cancer early detection test for firefighterson March 30, 2023 at 3:27 am
Chris Moore said. This week, the Chesapeake Fire Department is the first in Hampton Roads to team up with the company, GRAIL, to offer their Galleri multi-cancer early detection test. GRAIL officials ...
- Cancer-detection blood test made available to Chesapeake firefighterson March 29, 2023 at 3:01 pm
It's a lifesaving medical breakthrough for Chesapeake firefighters. On Wednesday, they rolled up their sleeves for a blood test that can detect 50 different cancers long before they have any symptoms.
- New technology illuminates bladder cancer detectionon March 29, 2023 at 8:19 am
UC San Diego Health is the first health system in San Diego County to offer a new technology that detects and monitors bladder cancer in both the clinic and operating room settings by using blue light ...
- Revolutionizing breast cancer detection: The power of AIon March 28, 2023 at 9:11 am
Doctors are using AI technology to detect signs of breast cancer, which could help lessen radiologists' workloads. Here's the artificial intelligence breakthrough.
- New blood test promises to detect cancerous tumors before they are formedon March 27, 2023 at 10:46 pm
In a trial of 1,000 participants — 500 non-cancer and 500 cancer patients — researchers were able to accurately anticipate the formation of tumors across ...
- Desert Regional Medical Center to offer new test for early cancer detectionon March 27, 2023 at 2:35 pm
When results are ready, the patient's doctor will get a report that indicates if there were or weren't cancer signals detected in the blood sample.
- ‘Holy grail’ of cancer detection predicts tumors a year before they form: breakthroughon March 27, 2023 at 2:18 pm
Following a radically successful trial on cancer patients, a new blood test that promises to predict tumors more than a year before they begin to form is now being applied in hospitals across the ...
- PGA Tour Champions tourney spreads word on Galleri early cancer detection teston March 26, 2023 at 1:35 pm
Bob Ragusa’s message about the Galleri Classic and the sponsorship of the event by Grail, Inc. is straight forward. “Our mission at Grail is to detect cancer early when it can be cured,” Ragusa said.
via Google News and Bing News